adyn

Biotechnology Research • Seattle, Washington, United States • 1-10 Employees

Company overview

Headquarters	Seattle, Washington, United States
Websites	adyn.com adynhealth.com
NAICS	541714
SIC	565
Founded	2020
Employees	1-10
Socials

Key Contact at adyn

Alpha Badio

Director

adyn Email Formats

adyn uses 2 email formats. The most common is {first name} (e.g., john@adyn.com), used 80% of the time.

Format	Example	Percentage
{first name}	john@adyn.com	80%
{first initial}	j@adyn.com	20%

About adyn

Founded by Dr. Elizabeth Ruzzo, adyn is helping people find birth control without side effects based on a person's genetic risk and hormone profile. Despite the 47M birth control users in the US, virtually no studies examine the biological factors that explain why individuals respond differently to a given contraceptive method. Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects. Our vision is to be earth’s most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.

adyn revenue & valuation

Annual revenue	$350,000
Revenue per employee	$44,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,200,000
Total funding	$2,500,000